Abiopharma

Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission

Perimeter Solutions Announces Proposed Offering of $550 Million Senior Secured Notes

Trinseo - Trinseo Announces Receipt of Notice of Non-Compliance With NYSE Continued Listing Requirements

Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer

Trinseo Announces Receipt of Notice of Non-Compliance With NYSE Continued Listing Requirements

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadics Recombinant Growth Factors and Media Proteins

Zoetis - Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering